WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS)
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924012476 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223622408372224 |
|---|---|
| author | Jonathon Barratt Anant Desai Alessia Fornoni Lesley Inker Irene de Lourdes Noronha Alejandra Quevedo Robert Shepherd Alisha Smith Hernan Trimarchi Lucila Valente Mona Wahba Muh Geot Wong Hiddo Lambers Heerspink |
| author_facet | Jonathon Barratt Anant Desai Alessia Fornoni Lesley Inker Irene de Lourdes Noronha Alejandra Quevedo Robert Shepherd Alisha Smith Hernan Trimarchi Lucila Valente Mona Wahba Muh Geot Wong Hiddo Lambers Heerspink |
| author_sort | Jonathon Barratt |
| collection | DOAJ |
| format | Article |
| id | doaj-art-a23b9121e4af4182a6e95f68ff9991c6 |
| institution | OA Journals |
| issn | 2468-0249 |
| language | English |
| publishDate | 2024-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-a23b9121e4af4182a6e95f68ff9991c62025-08-20T02:05:52ZengElsevierKidney International Reports2468-02492024-04-0194S550S55110.1016/j.ekir.2024.02.1158WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS)Jonathon Barratt0Anant Desai1Alessia Fornoni2Lesley Inker3Irene de Lourdes Noronha4Alejandra Quevedo5Robert Shepherd6Alisha Smith7Hernan Trimarchi8Lucila Valente9Mona Wahba10Muh Geot Wong11Hiddo Lambers Heerspink12Dept Cardiovascular Sciences, University of Leicester, LeicesterNephrology, Amicis Research Centre, CaliforniaPeggy and Harold Katz Family Drug Discovery Center, University of Miami, MiamiKidney and Blood Pressure Center, Tufts University, BostonNephrology, Hospital das Clínicas da Faculdade de Medicina da USP, Sao PauloNephrology, Centro Medico Dra Maffei Investigación Clínica Aplicad, Buenos AiresBD, Dimerix Bioscience Pty Ltd, FitzroyClinical, Dimerix Bioscience Pty Ltd, FitzroyNephrology Dept, Hospital Britáinico de Buenos Aires, Buenos AiresNephrology Dept, Hospital das Clinicas da UFPE, RECIFENephrology Dept, St Heliers Hospital, LondonRenal Medicine, Concord Repatriation General Hospital, ConcordDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningenhttp://www.sciencedirect.com/science/article/pii/S2468024924012476 |
| spellingShingle | Jonathon Barratt Anant Desai Alessia Fornoni Lesley Inker Irene de Lourdes Noronha Alejandra Quevedo Robert Shepherd Alisha Smith Hernan Trimarchi Lucila Valente Mona Wahba Muh Geot Wong Hiddo Lambers Heerspink WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS) Kidney International Reports |
| title | WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS) |
| title_full | WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS) |
| title_fullStr | WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS) |
| title_full_unstemmed | WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS) |
| title_short | WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS) |
| title_sort | wcn24 1132 action3 phase 3 study of dmx 200 for the treatment of focal segmental glomerulosclerosis fsgs |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924012476 |
| work_keys_str_mv | AT jonathonbarratt wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT anantdesai wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT alessiafornoni wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT lesleyinker wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT irenedelourdesnoronha wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT alejandraquevedo wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT robertshepherd wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT alishasmith wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT hernantrimarchi wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT lucilavalente wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT monawahba wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT muhgeotwong wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs AT hiddolambersheerspink wcn241132action3phase3studyofdmx200forthetreatmentoffocalsegmentalglomerulosclerosisfsgs |